, intercalative binding to DNA (Waring et al.. 1979; Yen et al., 1982) , and inhibition of DNA replication and transcription (Brana et al., 1981) have been described for some cationic naphthalimides, although no mention has been made on their use in fluorescence methods. Therefore, the aim of this work is to describe the microscopic fluorescence and emission character istics of some antitumoral naphthalimides.
Interestingly, strong antitumoral activity (Brana et al., 1980 (Brana et al., , 1981 (Brana et al., , 1993 McRipley et al., 1994; Bousquet et al., 1995) , intercalative binding to DNA (Waring et al.. 1979 ; Yen et al., 1982) , and inhibition of DNA replication and transcription (Brana et al., 1981) have been described for some cationic naphthalimides, although no mention has been made on their use in fluorescence methods. Therefore, the aim of this work is to describe the microscopic fluorescence and emission character istics of some antitumoral naphthalimides.
Smears of chicken blood were fixed in methanol for 2 min and air-dried. Samples of mouse liver, kidney, and large intestine were fixed in 3% glutaraldehyde in Sorensen's buffer at pH 6.8 for 24 h, dehydrated in ethanol and embedded in Epon 812 as usual (Glauert, 1975) . Semithin (1 -2 |im) sections were obtained with an Ultracut Reichert-Jung microtome, transferred to a drop of water on slides and then dried on a hot plate at 40 °C. Extraction methods for DNA were per formed on blood smears by treatment with DNase 1 (Serva, 0.5 mg/ml in 1 mM MgCl2 at 37 °C for 2 h), or 5% trichloroacetic acid (TCA) at boiling temperature for 15 min. Unstained smears and sections were also checked for autofluorescence.
Stock solutions (0.5 mg/ml) of the compounds (Fig. 1) obtained by synthesis as the free base (Knoll Laboratories, Madrid) were first made in acetic acid and then diluted with distilled water to the appropriate concentration. In all cases, final acetic acid concentration was 0.05%. Blood smears and Epon sections were stained, respec tively, with 20 and 50 jig/ml solutions of the com pounds for 5 min, washed in distilled water, airdried, and directly observed under oil immersion in a Zeiss photomicroscope III equipped with the epifluorescence condenser III RS, and the filter sets for ultraviolet (UV, 365 nm), violet (405 nm), and violet-blue (436 nm) exciting light. Microfluorometric measurements were carried out on eryth rocyte nuclei under 436 nm excitation, using the photometer head 03 (Zeiss), the HTVR 446 pho tomultiplier, and an uranyl glass as the emission standard. The highest fluorescence value was cho sen as 100%, and all the results were expressed as the mean ± standard deviation (SD) of this value.
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tensity was observed in erythrocyte nuclei (Fig. 1) . The highest green-yellow emission was found using the 3-aminonaphthalimides FA-142, FA-2043, and FA-2143, whereas 3-methoxy (FA-655) or 3-nitro derivatives (M-12210 and M-4212 [Mitonafide] ) showed very weak fluorescence. The strong emission of 3-aminonaphthalimides is ex plained because electron donors (such as the amino group) increase the fluorescence, while ni tro and alkoxy substituents are electron accepting groups which decrease the emission intensity (Rhys Williams, 1980; Stockert et al., 1994) . The aliphatic side chain linked to the naphthalimide Spectroscopic studies were perform ed on freshly made solutions (2 and 5 [ig/ml in 0.05% acetic acid) of the highest fluorescent compounds (FA-142 [Amonafide], FA-2043 and FA-2143, see Fig. 1 ) using a Shimadzu UV-1601 spectrophoto meter and a Perkin-Elm er 6 5 0 -10S fluorescence spectrophotom eter equipped with the R 372 F photomultiplier detector and 1 cm quartz cuvettes. The Raman scattering of solvents was subtracted from emission spectra.
After treatm ent of blood smears with the naph thalimide compounds, different fluorescence in fluorophore did not appear relevant. Optimal ex citations were 405 and 436 nm, and only a low fad ing rate occurred after prolonged irradiation.
Chromatin fluorescence induced by 3-aminonaphthalim ides was abolished after DNA extrac tion by DNase or TCA. No emission was found in other cells or cell structures from naphthalimidetreated smears. In addition to erythrocyte nuclei (Fig. 2a) , chromatin from tissue sections also showed strong fluorescence (Fig. 2b) . The mucin content of goblet cells appeared with considerable emission, probably due to the remaining hydrophilia of acid glycosaminoglycans in plastic sections Tato et al., 1991) .
Spectroscopic studies revealed absorption peaks at 346 and 408 nm for FA-142, whereas the fluo rescence emission appeared centered at 570 nm (Fig. 3) . O ther suitable excitations were 340, 380, 400 and 440 nm. Very similar absorption and emis sion spectra were also found for FA-2043 and FA-2143 . Emission features of these naphthalimides appeared well correlated with the bright greenyellow fluorescence of chromatin under violetblue (436 nm) excitation.
Taking into account the molecular structure of these compounds, chromatin fluorescence could be due to the intercalation of the naphthalimide fluorophore into DNA. Intercalative binding oc curs for unsubstituted (Yen et al., 1982) , 3-amino (Hsiang et al., 1989) , and 3-nitro derivatives (W ar ing et al., 1979; Chen et al., 1993) . The antitumoral FA-142 (Am onafide, currently used in clinical tri als [Saez et al., 1989] ) was also shown to inhibit DNA topoisom erase II and to form an intercalator-stabilized topo II-DNA cleavable complex (Hsiang et al., 1989) .
In view of the wide use of fluorescence tech niques in DNA cytochemistry and cell biology (Stockert et al., 1990; Rye et al., 1992; Stockert, 1992) , investigations on new fluorescent probes are of considerable interest, particularly those with biological activity (Villanueva et al., 1987; Stockert et al., 1989 Stockert et al., , 1991 M olero et al., 1995) . The fluorescence emission of some antitumoral naph thalimides is a very useful property of these DNAintercalating drugs, which could find im portant ap plications in biomedical research.
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